Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for RCOR1_MTA3
Z-value: 2.85
Motif logo
Transcription factors associated with RCOR1_MTA3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RCOR1
|
ENSG00000089902.10 | RCOR1 |
|
MTA3
|
ENSG00000057935.14 | MTA3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| RCOR1 | hg38_v1_chr14_+_102592611_102592668 | 0.39 | 2.0e-09 | Click! |
Activity profile of RCOR1_MTA3 motif
Sorted Z-values of RCOR1_MTA3 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of RCOR1_MTA3
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 52.6 | 157.9 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 46.7 | 186.9 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 45.6 | 182.4 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 44.3 | 133.0 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 42.9 | 171.8 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 40.0 | 160.1 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 39.8 | 159.4 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
| 39.1 | 156.3 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 37.8 | 226.8 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 37.5 | 112.4 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 37.2 | 111.6 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 36.8 | 147.3 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 36.1 | 72.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 36.1 | 72.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 35.8 | 107.5 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 35.7 | 178.4 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 33.9 | 135.7 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 33.5 | 100.6 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 33.4 | 367.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 32.8 | 98.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 32.0 | 160.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 31.3 | 125.1 | GO:0009216 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
| 31.1 | 249.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 31.0 | 155.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 30.2 | 120.7 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 30.1 | 30.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 30.1 | 90.3 | GO:0051793 | medium-chain fatty acid catabolic process(GO:0051793) |
| 30.0 | 150.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 29.9 | 89.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 29.5 | 88.4 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 29.1 | 87.4 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
| 29.1 | 87.3 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 29.1 | 87.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 28.9 | 86.6 | GO:0070650 | endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 28.8 | 86.5 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 28.7 | 401.4 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 28.6 | 114.5 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 28.6 | 85.8 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 28.4 | 85.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 28.1 | 84.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 27.7 | 193.8 | GO:0030421 | defecation(GO:0030421) |
| 27.6 | 192.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 27.3 | 109.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 27.1 | 81.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 26.9 | 107.6 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 26.9 | 80.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 26.8 | 80.3 | GO:0097698 | telomere maintenance via base-excision repair(GO:0097698) |
| 26.8 | 80.3 | GO:1901388 | regulation of transforming growth factor beta activation(GO:1901388) negative regulation of transforming growth factor beta activation(GO:1901389) |
| 26.4 | 132.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 26.3 | 52.5 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
| 25.7 | 51.5 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 25.7 | 77.0 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 25.4 | 76.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 25.4 | 127.0 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 25.2 | 50.5 | GO:0046075 | dTTP metabolic process(GO:0046075) |
| 25.2 | 176.6 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 24.9 | 323.4 | GO:0043248 | proteasome assembly(GO:0043248) |
| 24.8 | 24.8 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 24.7 | 271.2 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 24.6 | 98.4 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 24.4 | 97.5 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 24.2 | 532.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 24.1 | 24.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
| 24.1 | 72.3 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 24.0 | 143.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 23.9 | 143.4 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 23.9 | 191.0 | GO:0006561 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
| 23.9 | 143.2 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 23.9 | 334.1 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 23.8 | 47.7 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 23.5 | 188.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 23.4 | 70.2 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
| 23.4 | 70.1 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 23.2 | 162.6 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 23.2 | 92.6 | GO:0002188 | translation reinitiation(GO:0002188) |
| 23.1 | 231.2 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 23.0 | 115.2 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 22.9 | 206.2 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 22.9 | 343.4 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 22.8 | 182.0 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 22.6 | 90.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 22.2 | 88.8 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 22.0 | 110.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 21.7 | 86.8 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 21.6 | 64.7 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 21.4 | 150.0 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 21.3 | 63.8 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 21.2 | 42.5 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
| 21.2 | 318.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 21.2 | 63.6 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 21.2 | 63.5 | GO:0051182 | coenzyme transport(GO:0051182) |
| 21.2 | 105.8 | GO:0015862 | uridine transport(GO:0015862) |
| 21.0 | 105.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 21.0 | 315.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 21.0 | 62.9 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 20.9 | 1590.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 20.8 | 124.8 | GO:0007296 | vitellogenesis(GO:0007296) |
| 20.8 | 83.0 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 20.7 | 124.5 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
| 20.7 | 103.6 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 20.3 | 121.5 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 20.3 | 20.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 20.2 | 60.7 | GO:0015866 | ADP transport(GO:0015866) |
| 20.2 | 222.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 20.2 | 80.7 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
| 20.1 | 40.1 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 20.0 | 60.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 20.0 | 79.9 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 20.0 | 59.9 | GO:1903382 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 19.8 | 118.9 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 19.8 | 39.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 19.8 | 59.4 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 19.8 | 118.7 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 19.7 | 59.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 19.7 | 39.3 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 19.6 | 39.2 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 19.6 | 195.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 19.4 | 19.4 | GO:0009838 | abscission(GO:0009838) |
| 19.3 | 77.4 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 19.1 | 38.3 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 19.1 | 172.1 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 19.0 | 57.1 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 19.0 | 57.0 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 19.0 | 57.0 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 18.9 | 189.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 18.6 | 186.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 18.5 | 37.0 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 18.4 | 92.2 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 18.4 | 18.4 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
| 18.3 | 91.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 18.3 | 54.9 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 18.3 | 18.3 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 18.2 | 91.1 | GO:1902896 | terminal web assembly(GO:1902896) |
| 18.2 | 54.6 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 18.2 | 454.9 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 18.2 | 127.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 18.0 | 54.0 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 18.0 | 107.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 17.9 | 35.9 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 17.9 | 53.8 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 17.9 | 250.9 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 17.9 | 35.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 17.8 | 178.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 17.8 | 1742.4 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
| 17.8 | 71.0 | GO:1903788 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 17.7 | 53.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 17.7 | 53.2 | GO:0075732 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 17.6 | 52.9 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 17.6 | 123.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 17.6 | 52.7 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
| 17.6 | 52.7 | GO:0035732 | nitric oxide storage(GO:0035732) |
| 17.5 | 70.1 | GO:0030047 | actin modification(GO:0030047) |
| 17.5 | 35.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 17.5 | 87.5 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 17.3 | 52.0 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 17.3 | 69.4 | GO:0032600 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 17.3 | 51.8 | GO:1904387 | response to human chorionic gonadotropin(GO:0044752) cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 17.3 | 103.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 17.3 | 69.0 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 17.2 | 103.0 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 17.1 | 68.5 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 17.1 | 68.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 17.0 | 101.7 | GO:0015853 | adenine transport(GO:0015853) |
| 16.9 | 50.7 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 16.9 | 84.4 | GO:0035900 | response to isolation stress(GO:0035900) |
| 16.8 | 50.3 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 16.7 | 50.2 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 16.7 | 16.7 | GO:0048378 | lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 16.7 | 50.1 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 16.6 | 282.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 16.5 | 66.0 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 16.5 | 98.8 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 16.4 | 82.2 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 16.4 | 16.4 | GO:0048254 | snoRNA localization(GO:0048254) |
| 16.3 | 179.4 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 16.3 | 81.4 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 16.2 | 210.7 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 16.2 | 145.7 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 16.2 | 210.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 16.2 | 48.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 16.1 | 112.8 | GO:0032218 | riboflavin transport(GO:0032218) |
| 16.0 | 64.0 | GO:0007144 | female meiosis I(GO:0007144) |
| 15.9 | 79.7 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
| 15.9 | 444.7 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 15.8 | 252.6 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 15.8 | 47.3 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 15.8 | 157.8 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 15.8 | 141.9 | GO:2000582 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 15.7 | 15.7 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 15.7 | 15.7 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 15.5 | 77.7 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 15.5 | 124.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 15.5 | 185.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 15.5 | 108.3 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 15.5 | 123.8 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 15.4 | 138.9 | GO:0042262 | DNA protection(GO:0042262) |
| 15.4 | 107.9 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 15.4 | 46.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 15.4 | 30.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 15.4 | 76.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 15.3 | 91.7 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 15.3 | 183.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 15.2 | 30.5 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 15.2 | 45.6 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 15.2 | 30.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 15.1 | 15.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 15.0 | 134.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 15.0 | 59.8 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 14.7 | 14.7 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
| 14.7 | 73.3 | GO:1904753 | negative regulation of vascular associated smooth muscle cell migration(GO:1904753) |
| 14.7 | 117.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 14.6 | 58.6 | GO:0018032 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 14.6 | 73.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 14.6 | 14.6 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
| 14.6 | 58.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 14.5 | 202.9 | GO:0030497 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
| 14.5 | 462.9 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 14.4 | 43.3 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 14.4 | 57.7 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 14.4 | 100.8 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 14.4 | 43.1 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 14.3 | 157.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 14.3 | 328.5 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 14.2 | 42.7 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 14.2 | 924.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 14.2 | 42.6 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 14.1 | 155.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 14.1 | 225.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 14.0 | 42.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 14.0 | 14.0 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 13.9 | 55.4 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
| 13.8 | 55.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 13.8 | 96.7 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 13.8 | 55.2 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 13.8 | 27.6 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 13.7 | 13.7 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
| 13.7 | 109.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 13.7 | 68.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 13.6 | 54.6 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 13.6 | 40.9 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 13.6 | 40.9 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 13.6 | 40.7 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 13.6 | 81.4 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 13.6 | 27.1 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 13.5 | 13.5 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 13.5 | 40.4 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 13.4 | 40.1 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
| 13.3 | 585.4 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 13.3 | 39.9 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 13.3 | 53.0 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 13.2 | 39.7 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 13.2 | 39.7 | GO:1900161 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 13.2 | 26.3 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 13.1 | 26.3 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 13.1 | 52.5 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 13.1 | 26.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 13.1 | 52.4 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 13.1 | 39.2 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 13.1 | 78.4 | GO:0042407 | cristae formation(GO:0042407) |
| 13.0 | 142.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 13.0 | 51.9 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 12.9 | 12.9 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 12.9 | 38.7 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 12.9 | 64.3 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
| 12.8 | 12.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
| 12.8 | 166.6 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 12.8 | 370.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 12.7 | 63.7 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
| 12.7 | 152.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 12.6 | 37.7 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 12.6 | 12.6 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 12.6 | 150.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 12.5 | 50.0 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 12.5 | 74.9 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 12.5 | 112.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 12.5 | 49.9 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 12.5 | 24.9 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 12.5 | 249.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 12.4 | 24.8 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 12.4 | 62.0 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 12.4 | 37.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 12.4 | 37.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 12.4 | 61.8 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 12.3 | 111.1 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
| 12.3 | 61.7 | GO:1902903 | regulation of fibril organization(GO:1902903) |
| 12.3 | 258.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 12.3 | 49.1 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 12.2 | 12.2 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 12.2 | 60.9 | GO:0060613 | fat pad development(GO:0060613) |
| 12.2 | 12.2 | GO:0090135 | actin filament branching(GO:0090135) |
| 12.2 | 36.5 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 12.1 | 84.9 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 12.1 | 109.0 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 12.1 | 60.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 12.1 | 36.2 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 12.1 | 217.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 12.0 | 84.2 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 12.0 | 156.2 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 12.0 | 335.6 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 12.0 | 419.0 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 11.9 | 95.2 | GO:0006265 | DNA topological change(GO:0006265) |
| 11.8 | 11.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 11.8 | 35.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 11.8 | 58.9 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 11.8 | 35.3 | GO:0044830 | modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 11.7 | 11.7 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 11.7 | 93.5 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 11.7 | 46.7 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
| 11.7 | 46.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 11.7 | 35.0 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
| 11.6 | 46.6 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 11.5 | 115.5 | GO:0009414 | response to water deprivation(GO:0009414) |
| 11.5 | 34.6 | GO:1903332 | regulation of protein folding(GO:1903332) |
| 11.5 | 115.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 11.5 | 34.6 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 11.4 | 114.3 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 11.4 | 22.9 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 11.4 | 68.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 11.4 | 45.5 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 11.3 | 11.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 11.3 | 124.5 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 11.3 | 33.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 11.3 | 33.8 | GO:0060957 | endocardial cell fate commitment(GO:0060957) endocardial cushion cell fate commitment(GO:0061445) |
| 11.3 | 22.5 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 11.2 | 44.9 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 11.2 | 133.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 11.2 | 33.5 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 11.1 | 33.4 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 11.1 | 11.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
| 11.0 | 121.5 | GO:0045116 | protein neddylation(GO:0045116) |
| 11.0 | 44.1 | GO:0072683 | T cell extravasation(GO:0072683) |
| 11.0 | 187.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 11.0 | 33.0 | GO:1903542 | epidermal growth factor catabolic process(GO:0007174) negative regulation of exosomal secretion(GO:1903542) |
| 11.0 | 11.0 | GO:0060066 | oviduct development(GO:0060066) |
| 11.0 | 22.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 11.0 | 109.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 11.0 | 54.8 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 11.0 | 21.9 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 10.9 | 65.7 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 10.9 | 98.2 | GO:0002934 | desmosome organization(GO:0002934) |
| 10.9 | 76.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 10.9 | 32.6 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 10.9 | 43.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 10.8 | 10.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 10.8 | 161.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 10.8 | 21.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 10.8 | 75.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 10.8 | 53.8 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 10.8 | 21.5 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 10.7 | 10.7 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 10.7 | 32.1 | GO:1902568 | regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 10.7 | 21.4 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 10.7 | 64.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 10.7 | 74.6 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 10.5 | 42.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 10.5 | 295.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 10.5 | 31.6 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 10.5 | 52.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 10.5 | 31.4 | GO:2000619 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 10.5 | 73.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 10.4 | 94.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 10.4 | 104.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 10.4 | 104.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 10.4 | 41.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 10.4 | 31.2 | GO:0060739 | mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 10.3 | 20.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 10.3 | 92.8 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 10.3 | 41.0 | GO:0010138 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) |
| 10.2 | 10.2 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 10.2 | 133.0 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 10.1 | 121.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 10.0 | 49.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 9.9 | 59.5 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 9.9 | 49.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 9.9 | 59.2 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 9.8 | 39.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 9.8 | 185.5 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 9.7 | 29.2 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 9.7 | 632.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 9.7 | 58.1 | GO:0042182 | ketone catabolic process(GO:0042182) |
| 9.7 | 174.4 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 9.7 | 135.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 9.7 | 38.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 9.7 | 67.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 9.6 | 67.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 9.6 | 9.6 | GO:0051095 | regulation of helicase activity(GO:0051095) |
| 9.5 | 38.2 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 9.5 | 66.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 9.5 | 95.2 | GO:0060717 | chorion development(GO:0060717) |
| 9.5 | 57.1 | GO:0015677 | copper ion import(GO:0015677) |
| 9.5 | 56.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 9.4 | 292.9 | GO:0090383 | phagosome acidification(GO:0090383) |
| 9.4 | 37.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 9.4 | 37.7 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 9.4 | 216.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 9.4 | 103.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 9.4 | 9.4 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 9.4 | 18.7 | GO:0070384 | Harderian gland development(GO:0070384) |
| 9.3 | 83.4 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 9.2 | 129.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 9.2 | 27.6 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 9.1 | 118.7 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 9.1 | 9.1 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 9.1 | 9.1 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) |
| 9.1 | 18.2 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 9.1 | 63.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 9.1 | 45.3 | GO:0006574 | valine catabolic process(GO:0006574) |
| 9.1 | 199.5 | GO:0042775 | ATP synthesis coupled electron transport(GO:0042773) mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 9.1 | 27.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 9.0 | 343.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 9.0 | 153.4 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 9.0 | 9.0 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 9.0 | 35.9 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 9.0 | 17.9 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 8.9 | 71.5 | GO:0046689 | response to mercury ion(GO:0046689) |
| 8.9 | 26.8 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 8.9 | 62.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 8.9 | 62.1 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
| 8.9 | 53.2 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 8.9 | 44.3 | GO:1903301 | positive regulation of hexokinase activity(GO:1903301) |
| 8.8 | 8.8 | GO:1901355 | response to rapamycin(GO:1901355) |
| 8.7 | 26.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 8.7 | 8.7 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 8.7 | 103.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 8.7 | 43.3 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 8.7 | 26.0 | GO:0090176 | microtubule cytoskeleton organization involved in establishment of planar polarity(GO:0090176) |
| 8.7 | 43.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 8.6 | 8.6 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 8.6 | 188.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 8.6 | 17.1 | GO:0007412 | axon target recognition(GO:0007412) |
| 8.5 | 25.6 | GO:0051795 | positive regulation of catagen(GO:0051795) |
| 8.5 | 290.2 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 8.5 | 42.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 8.5 | 42.5 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 8.5 | 51.0 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 8.5 | 8.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 8.5 | 16.9 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
| 8.4 | 8.4 | GO:0034214 | protein hexamerization(GO:0034214) |
| 8.4 | 8.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 8.4 | 8.4 | GO:0016488 | sesquiterpenoid metabolic process(GO:0006714) polyprenol catabolic process(GO:0016095) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 8.4 | 50.5 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 8.4 | 25.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 8.4 | 58.5 | GO:0090647 | modulation of age-related behavioral decline(GO:0090647) |
| 8.4 | 91.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 8.3 | 25.0 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 8.3 | 8.3 | GO:1902822 | regulation of late endosome to lysosome transport(GO:1902822) |
| 8.3 | 24.8 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 8.2 | 8.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 8.2 | 106.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 8.1 | 170.6 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 8.1 | 24.4 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 8.1 | 24.4 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 8.1 | 48.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 8.1 | 48.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 8.1 | 32.3 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 8.1 | 48.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 8.1 | 112.9 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 8.1 | 56.5 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 8.1 | 16.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 8.1 | 16.1 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 8.1 | 32.2 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 8.0 | 483.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 8.0 | 8.0 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 8.0 | 24.0 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 8.0 | 615.4 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
| 8.0 | 103.9 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 8.0 | 230.8 | GO:0006465 | signal peptide processing(GO:0006465) |
| 8.0 | 47.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 7.9 | 23.8 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 7.9 | 79.4 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 7.9 | 15.9 | GO:0072019 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 7.9 | 39.5 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 7.9 | 31.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 7.9 | 15.7 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 7.9 | 55.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 7.8 | 54.9 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 7.8 | 54.8 | GO:0030091 | protein repair(GO:0030091) |
| 7.8 | 23.4 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 7.7 | 15.5 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 7.7 | 46.4 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 7.7 | 46.2 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 7.7 | 30.8 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 7.7 | 23.1 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 7.7 | 200.3 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 7.7 | 7.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 7.7 | 15.3 | GO:1904732 | regulation of electron carrier activity(GO:1904732) |
| 7.6 | 22.9 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 7.6 | 91.5 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 7.6 | 22.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 7.6 | 15.1 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 7.6 | 15.1 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 7.5 | 30.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
| 7.5 | 22.6 | GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) |
| 7.5 | 60.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 7.5 | 37.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 7.5 | 74.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 7.5 | 7.5 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 7.4 | 29.8 | GO:1905216 | positive regulation of RNA binding(GO:1905216) |
| 7.4 | 51.9 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 7.4 | 14.8 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
| 7.4 | 22.2 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 7.4 | 103.2 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 7.4 | 132.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 7.3 | 44.0 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
| 7.3 | 117.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 7.3 | 43.8 | GO:0000012 | single strand break repair(GO:0000012) |
| 7.3 | 21.8 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 7.3 | 14.5 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 7.3 | 29.0 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 7.2 | 28.9 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 7.2 | 86.8 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 7.2 | 35.9 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 7.1 | 285.6 | GO:0035329 | hippo signaling(GO:0035329) |
| 7.1 | 49.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 7.1 | 63.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 7.1 | 28.3 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 7.1 | 42.5 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 7.0 | 28.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 7.0 | 7.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 7.0 | 21.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 7.0 | 77.4 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 7.0 | 84.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 7.0 | 56.1 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 6.9 | 6.9 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 6.9 | 186.6 | GO:0042255 | ribosome assembly(GO:0042255) |
| 6.9 | 48.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 6.9 | 55.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 6.9 | 68.9 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 6.8 | 61.6 | GO:0006983 | ER overload response(GO:0006983) |
| 6.8 | 6.8 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 6.8 | 34.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
| 6.8 | 47.4 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
| 6.7 | 33.7 | GO:1900368 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
| 6.7 | 13.4 | GO:0046203 | spermidine catabolic process(GO:0046203) |
| 6.7 | 107.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 6.7 | 13.4 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
| 6.7 | 20.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 6.7 | 40.1 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 6.6 | 26.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 6.6 | 19.7 | GO:0042946 | glucoside transport(GO:0042946) |
| 6.6 | 6.6 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 6.6 | 105.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 6.6 | 65.6 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
| 6.5 | 39.3 | GO:0060356 | leucine import(GO:0060356) |
| 6.5 | 19.6 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 6.5 | 19.6 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 6.5 | 175.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 6.5 | 39.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 6.5 | 38.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 6.5 | 32.3 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 6.4 | 19.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 6.4 | 90.0 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 6.4 | 6.4 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 6.4 | 77.0 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 6.4 | 19.2 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 6.3 | 88.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 6.3 | 12.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 6.3 | 19.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 6.3 | 50.5 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 6.3 | 101.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 6.3 | 25.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 6.3 | 25.2 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 6.3 | 31.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 6.3 | 18.9 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 6.3 | 81.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 6.3 | 106.5 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 6.2 | 56.0 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 6.2 | 37.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 6.2 | 6.2 | GO:0070487 | monocyte aggregation(GO:0070487) |
| 6.2 | 68.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 6.2 | 357.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 6.1 | 12.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 6.1 | 164.8 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 6.1 | 18.3 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 6.1 | 6.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 6.0 | 24.1 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 6.0 | 48.1 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 6.0 | 30.0 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 5.9 | 5.9 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 5.9 | 35.5 | GO:0045914 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 5.9 | 94.2 | GO:0097264 | self proteolysis(GO:0097264) |
| 5.8 | 58.5 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
| 5.8 | 23.2 | GO:0016559 | peroxisome fission(GO:0016559) |
| 5.8 | 11.6 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 5.8 | 17.3 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 5.8 | 11.5 | GO:0097033 | mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 5.8 | 5.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 5.7 | 28.7 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 5.7 | 28.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 5.7 | 34.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 5.7 | 56.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 5.7 | 164.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 5.7 | 28.3 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 5.6 | 5.6 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 5.6 | 45.1 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 5.6 | 39.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 5.6 | 16.8 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 5.6 | 22.3 | GO:0052501 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 5.6 | 72.4 | GO:0031639 | plasminogen activation(GO:0031639) |
| 5.5 | 16.6 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 5.5 | 11.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 5.5 | 66.0 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 5.5 | 38.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 5.5 | 43.7 | GO:2000587 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 5.4 | 27.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 5.4 | 21.7 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 5.4 | 64.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 5.4 | 32.4 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) positive regulation of transforming growth factor beta3 production(GO:0032916) response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) negative regulation of lung blood pressure(GO:0061767) response to host(GO:0075136) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 5.4 | 26.8 | GO:1903299 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
| 5.3 | 10.6 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 5.3 | 37.1 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 5.3 | 5.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 5.3 | 21.2 | GO:0018201 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 5.3 | 132.2 | GO:0051031 | tRNA transport(GO:0051031) |
| 5.3 | 179.7 | GO:0007031 | peroxisome organization(GO:0007031) |
| 5.3 | 21.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 5.2 | 10.5 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 5.2 | 15.7 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 5.2 | 10.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 5.2 | 244.1 | GO:0018208 | protein peptidyl-prolyl isomerization(GO:0000413) peptidyl-proline modification(GO:0018208) |
| 5.2 | 15.5 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 5.2 | 51.7 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 5.1 | 5.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 5.1 | 5.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 5.1 | 71.7 | GO:0070986 | left/right axis specification(GO:0070986) |
| 5.1 | 30.7 | GO:0006563 | L-serine metabolic process(GO:0006563) |
| 5.1 | 15.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 5.1 | 61.2 | GO:0006903 | vesicle targeting(GO:0006903) |
| 5.1 | 66.2 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 5.1 | 5.1 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
| 5.1 | 25.3 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 5.0 | 35.3 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 5.0 | 5.0 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 5.0 | 30.1 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 5.0 | 20.1 | GO:0006595 | polyamine metabolic process(GO:0006595) |
| 5.0 | 40.0 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 5.0 | 5.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 5.0 | 15.0 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
| 4.9 | 69.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 4.9 | 4.9 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 4.9 | 19.7 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 4.9 | 58.9 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
| 4.9 | 24.5 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 4.9 | 4.9 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 4.9 | 29.3 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 4.9 | 4.9 | GO:0021815 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
| 4.9 | 19.4 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 4.9 | 9.7 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
| 4.8 | 33.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 4.8 | 9.7 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
| 4.8 | 19.3 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 4.8 | 77.3 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
| 4.8 | 47.9 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
| 4.8 | 43.1 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 4.8 | 33.5 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 4.8 | 33.4 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 4.8 | 9.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) negative regulation of immunological synapse formation(GO:2000521) |
| 4.7 | 28.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 4.7 | 9.4 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 4.7 | 28.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 4.7 | 60.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 4.7 | 55.9 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 4.7 | 46.5 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 4.6 | 18.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 4.6 | 4.6 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 4.6 | 18.5 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 4.6 | 13.8 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 4.6 | 91.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 4.6 | 18.3 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 4.6 | 4.6 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 4.6 | 4.6 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
| 4.6 | 13.7 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 4.5 | 9.1 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
| 4.5 | 4.5 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 4.5 | 13.6 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 4.5 | 45.1 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 4.5 | 63.0 | GO:0044786 | cell cycle DNA replication(GO:0044786) |
| 4.4 | 4.4 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 4.4 | 129.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 4.4 | 13.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
| 4.4 | 8.9 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 4.4 | 66.4 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
| 4.4 | 101.8 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 4.4 | 115.0 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 4.4 | 70.7 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
| 4.4 | 4.4 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 4.4 | 22.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 4.4 | 4.4 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
| 4.4 | 8.8 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 4.4 | 52.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 4.4 | 8.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 4.4 | 8.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 4.3 | 17.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 4.3 | 13.0 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 4.3 | 21.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 4.3 | 4.3 | GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051343) |
| 4.3 | 30.1 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 4.3 | 38.6 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 4.3 | 8.6 | GO:0032765 | regulation of mast cell cytokine production(GO:0032763) positive regulation of mast cell cytokine production(GO:0032765) |
| 4.3 | 12.8 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 4.3 | 4.3 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 4.2 | 38.2 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
| 4.2 | 16.9 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 4.2 | 67.2 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 4.2 | 41.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 4.1 | 12.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 4.1 | 24.7 | GO:0019532 | oxalate transport(GO:0019532) |
| 4.1 | 205.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 4.1 | 16.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 4.1 | 163.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 4.1 | 8.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 4.1 | 4.1 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 4.1 | 20.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 4.1 | 12.2 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 4.1 | 44.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 4.0 | 8.1 | GO:0060437 | lung growth(GO:0060437) |
| 4.0 | 12.1 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 4.0 | 24.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 4.0 | 59.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 4.0 | 23.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 4.0 | 4.0 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 4.0 | 7.9 | GO:0043335 | protein unfolding(GO:0043335) |
| 3.9 | 3.9 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 3.9 | 43.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 3.9 | 23.6 | GO:0010829 | negative regulation of glucose transport(GO:0010829) |
| 3.9 | 23.5 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 3.9 | 47.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 3.9 | 23.5 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
| 3.9 | 3.9 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
| 3.9 | 224.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 3.9 | 65.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 3.8 | 11.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 3.8 | 30.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 3.8 | 15.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 3.8 | 52.7 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 3.8 | 33.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 3.8 | 52.6 | GO:0043486 | histone exchange(GO:0043486) |
| 3.8 | 41.3 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 3.7 | 18.7 | GO:0048596 | embryonic camera-type eye morphogenesis(GO:0048596) |
| 3.7 | 3.7 | GO:0051458 | corticotropin secretion(GO:0051458) |
| 3.7 | 14.9 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 3.7 | 14.8 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
| 3.7 | 33.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 3.6 | 14.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 3.6 | 10.9 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 3.6 | 10.9 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 3.6 | 18.1 | GO:0051451 | myoblast migration(GO:0051451) |
| 3.6 | 14.4 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 3.6 | 7.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
| 3.6 | 14.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 3.6 | 24.9 | GO:1901295 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
| 3.5 | 14.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 3.5 | 17.7 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 3.5 | 10.6 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
| 3.5 | 3.5 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 3.5 | 31.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 3.5 | 24.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 3.5 | 14.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 3.5 | 7.0 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
| 3.5 | 3.5 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 3.5 | 13.9 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 3.5 | 17.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 3.5 | 72.5 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
| 3.5 | 41.4 | GO:0046040 | IMP metabolic process(GO:0046040) |
| 3.4 | 41.4 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
| 3.4 | 189.6 | GO:0006364 | rRNA processing(GO:0006364) |
| 3.4 | 31.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 3.4 | 17.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 3.4 | 13.6 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 3.4 | 6.8 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 3.4 | 94.6 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 3.4 | 16.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 3.4 | 13.5 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 3.4 | 16.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 3.4 | 6.7 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 3.3 | 20.1 | GO:0097421 | liver regeneration(GO:0097421) |
| 3.3 | 13.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 3.3 | 20.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 3.3 | 10.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 3.3 | 3.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 3.3 | 9.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 3.3 | 16.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
| 3.3 | 9.8 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 3.3 | 22.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 3.2 | 12.9 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 3.2 | 16.1 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 3.2 | 9.6 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 3.2 | 9.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 3.2 | 57.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 3.2 | 19.1 | GO:0070345 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) negative regulation of fat cell proliferation(GO:0070345) |
| 3.2 | 3.2 | GO:0035973 | aggrephagy(GO:0035973) |
| 3.2 | 22.2 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 3.2 | 19.0 | GO:0061205 | alveolar primary septum development(GO:0061143) paramesonephric duct development(GO:0061205) |
| 3.2 | 12.6 | GO:0009956 | radial pattern formation(GO:0009956) |
| 3.1 | 22.0 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 3.1 | 18.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 3.1 | 72.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
| 3.1 | 3.1 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 3.1 | 31.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 3.1 | 37.5 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
| 3.1 | 6.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
| 3.1 | 12.4 | GO:1990834 | response to odorant(GO:1990834) |
| 3.1 | 52.5 | GO:0006739 | NADP metabolic process(GO:0006739) |
| 3.1 | 30.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 3.1 | 189.8 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 3.1 | 277.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 3.0 | 895.7 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
| 3.0 | 91.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 3.0 | 15.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 3.0 | 33.2 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
| 3.0 | 42.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 3.0 | 30.1 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 3.0 | 3.0 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 3.0 | 5.9 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 3.0 | 3.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 3.0 | 17.8 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 2.9 | 79.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 2.9 | 5.9 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 2.9 | 5.9 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 2.9 | 11.7 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 2.9 | 35.0 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 2.9 | 8.7 | GO:0010288 | response to lead ion(GO:0010288) |
| 2.9 | 8.7 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
| 2.9 | 8.7 | GO:0035425 | autocrine signaling(GO:0035425) |
| 2.9 | 14.4 | GO:1903027 | regulation of opsonization(GO:1903027) |
| 2.9 | 5.7 | GO:0070198 | protein localization to chromosome, telomeric region(GO:0070198) |
| 2.9 | 11.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 2.9 | 37.1 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 2.8 | 17.1 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 2.8 | 8.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 2.8 | 11.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 2.8 | 11.2 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
| 2.8 | 61.8 | GO:0006301 | postreplication repair(GO:0006301) |
| 2.8 | 2.8 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
| 2.8 | 5.6 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 2.8 | 11.1 | GO:0061146 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
| 2.8 | 8.3 | GO:0048840 | otolith development(GO:0048840) |
| 2.8 | 19.4 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 2.8 | 5.5 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 2.8 | 145.9 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 2.7 | 2.7 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 2.7 | 177.9 | GO:0006413 | translational initiation(GO:0006413) |
| 2.7 | 24.6 | GO:0031947 | negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of hormone biosynthetic process(GO:0032353) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 2.7 | 8.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 2.7 | 16.4 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 2.7 | 206.9 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 2.7 | 8.1 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 2.7 | 32.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 2.7 | 2.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 2.7 | 5.3 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 2.7 | 18.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 2.7 | 8.0 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
| 2.6 | 2.6 | GO:0061443 | endocardial cushion cell differentiation(GO:0061443) |
| 2.6 | 5.3 | GO:0006266 | DNA ligation(GO:0006266) |
| 2.6 | 20.9 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 2.6 | 2.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 2.6 | 59.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 2.6 | 20.8 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 2.6 | 5.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 2.6 | 62.3 | GO:0032392 | DNA geometric change(GO:0032392) |
| 2.6 | 2.6 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 2.6 | 7.7 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 2.6 | 5.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 2.5 | 10.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 2.5 | 15.2 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 2.5 | 10.1 | GO:0015825 | L-serine transport(GO:0015825) |
| 2.5 | 17.7 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 2.5 | 32.6 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
| 2.5 | 7.5 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 2.5 | 57.1 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 2.5 | 2.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 2.5 | 4.9 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 2.5 | 12.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 2.4 | 7.3 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
| 2.4 | 14.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 2.4 | 41.2 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 2.4 | 9.7 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 2.4 | 9.6 | GO:0035803 | egg coat formation(GO:0035803) |
| 2.4 | 14.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 2.4 | 4.7 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 2.4 | 9.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 2.3 | 37.5 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 2.3 | 11.7 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 2.3 | 11.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 2.3 | 71.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
| 2.3 | 25.1 | GO:1904778 | protein localization to cell cortex(GO:0072697) regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 2.3 | 50.0 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
| 2.3 | 2.3 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
| 2.2 | 4.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 2.2 | 6.7 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 2.2 | 13.4 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
| 2.2 | 33.5 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 2.2 | 6.7 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
| 2.2 | 17.6 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 2.2 | 19.8 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 2.2 | 4.4 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
| 2.2 | 8.7 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
| 2.2 | 4.3 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 2.2 | 19.5 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
| 2.2 | 17.3 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 2.1 | 8.6 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 2.1 | 6.4 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 2.1 | 2.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 2.1 | 59.4 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
| 2.1 | 6.3 | GO:0043038 | amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
| 2.1 | 50.5 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 2.1 | 2.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 2.1 | 20.5 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 2.1 | 6.2 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 2.0 | 4.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 2.0 | 8.1 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 2.0 | 57.8 | GO:0006582 | melanin metabolic process(GO:0006582) |
| 2.0 | 21.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 2.0 | 4.0 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 2.0 | 13.8 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 1.9 | 17.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 1.9 | 7.8 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 1.9 | 1.9 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) regulation of ubiquitin-specific protease activity(GO:2000152) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 1.9 | 3.9 | GO:0072143 | mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
| 1.9 | 7.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 1.9 | 5.7 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.9 | 3.8 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 1.9 | 16.9 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
| 1.9 | 7.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 1.9 | 9.3 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 1.9 | 31.5 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 1.9 | 29.6 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 1.8 | 7.2 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 1.8 | 7.1 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 1.8 | 1.8 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 1.8 | 8.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 1.8 | 7.1 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
| 1.8 | 5.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.7 | 19.2 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 1.7 | 21.0 | GO:0033572 | transferrin transport(GO:0033572) |
| 1.7 | 7.0 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
| 1.7 | 17.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 1.7 | 5.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 1.7 | 5.0 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 1.7 | 1.7 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
| 1.7 | 13.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 1.6 | 1.6 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 1.6 | 1.6 | GO:0007343 | egg activation(GO:0007343) |
| 1.6 | 1.6 | GO:0061009 | common bile duct development(GO:0061009) |
| 1.6 | 11.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 1.6 | 4.7 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 1.6 | 7.8 | GO:0001302 | replicative cell aging(GO:0001302) |
| 1.6 | 9.4 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 1.5 | 3.1 | GO:2000909 | regulation of high-density lipoprotein particle clearance(GO:0010982) regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
| 1.5 | 6.1 | GO:0035549 | positive regulation of interferon-beta secretion(GO:0035549) |
| 1.5 | 4.6 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 1.5 | 45.7 | GO:0043090 | amino acid import(GO:0043090) |
| 1.5 | 4.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 1.5 | 3.0 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 1.5 | 7.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 1.5 | 4.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 1.5 | 7.4 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 1.5 | 4.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 1.5 | 5.8 | GO:0072319 | vesicle uncoating(GO:0072319) |
| 1.4 | 12.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 1.4 | 4.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 1.4 | 5.6 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 1.4 | 12.6 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 1.4 | 4.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 1.4 | 24.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 1.4 | 1.4 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
| 1.4 | 6.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 1.4 | 6.9 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 1.4 | 9.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 1.4 | 1.4 | GO:0060166 | olfactory pit development(GO:0060166) |
| 1.4 | 5.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
| 1.3 | 8.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 1.3 | 34.9 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 1.3 | 14.6 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 1.3 | 4.0 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
| 1.3 | 9.2 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 1.3 | 2.6 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 1.3 | 2.6 | GO:1903937 | response to acrylamide(GO:1903937) |
| 1.3 | 3.8 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 1.3 | 11.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.3 | 12.7 | GO:0051452 | intracellular pH reduction(GO:0051452) |
| 1.2 | 2.4 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 1.2 | 4.7 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 1.2 | 5.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 1.2 | 23.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 1.1 | 59.7 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 1.1 | 16.0 | GO:0006415 | translational termination(GO:0006415) |
| 1.1 | 48.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 1.1 | 44.9 | GO:0045214 | sarcomere organization(GO:0045214) |
| 1.1 | 4.5 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
| 1.1 | 11.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 1.1 | 9.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 1.1 | 18.7 | GO:0032060 | bleb assembly(GO:0032060) |
| 1.1 | 2.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 1.1 | 14.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 1.1 | 3.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 1.1 | 2.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
| 1.1 | 36.0 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 1.0 | 2.1 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
| 1.0 | 2.0 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 1.0 | 17.0 | GO:0051923 | sulfation(GO:0051923) |
| 1.0 | 1.0 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 1.0 | 8.9 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
| 1.0 | 1.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 1.0 | 3.8 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.9 | 32.2 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
| 0.9 | 9.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.9 | 0.9 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.9 | 5.6 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.9 | 1.8 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.9 | 21.9 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.9 | 14.6 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.9 | 13.5 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.9 | 11.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.9 | 5.3 | GO:0001782 | B cell homeostasis(GO:0001782) |
| 0.9 | 1.8 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.9 | 7.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.8 | 1.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.8 | 6.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.8 | 4.9 | GO:0008206 | bile acid metabolic process(GO:0008206) |
| 0.8 | 28.4 | GO:0046034 | ATP metabolic process(GO:0046034) |
| 0.8 | 1.6 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.8 | 4.8 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.7 | 7.5 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
| 0.7 | 3.7 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.7 | 5.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.7 | 0.7 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
| 0.7 | 5.9 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) |
| 0.7 | 5.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.7 | 2.2 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
| 0.7 | 1.4 | GO:1902741 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.7 | 2.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.6 | 0.6 | GO:0032423 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
| 0.6 | 0.6 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.6 | 1.3 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.6 | 0.6 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.6 | 6.0 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.6 | 1.8 | GO:0061087 | regulation of histone H3-K27 methylation(GO:0061085) positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.6 | 1.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.6 | 18.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
| 0.5 | 12.9 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.5 | 6.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.5 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.5 | 1.6 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 0.5 | 8.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.5 | 1.5 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.5 | 13.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.5 | 4.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.5 | 2.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.5 | 4.8 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.5 | 1.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.5 | 1.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.5 | 0.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.5 | 3.8 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.5 | 2.8 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.5 | 1.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.4 | 4.9 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.4 | 3.1 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.4 | 3.5 | GO:1904385 | cellular response to angiotensin(GO:1904385) |
| 0.4 | 2.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.4 | 0.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.4 | 0.4 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.4 | 3.3 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.4 | 2.4 | GO:0021591 | ventricular system development(GO:0021591) |
| 0.4 | 2.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.4 | 7.0 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.4 | 1.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.4 | 7.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.4 | 1.4 | GO:0060013 | righting reflex(GO:0060013) |
| 0.3 | 0.7 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.3 | 0.3 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) endoplasmic reticulum membrane organization(GO:0090158) |
| 0.3 | 4.1 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.3 | 3.0 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.3 | 0.7 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
| 0.3 | 6.2 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.3 | 0.3 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.3 | 0.9 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.3 | 0.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.3 | 2.6 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.2 | 0.2 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
| 0.2 | 0.2 | GO:0036296 | response to increased oxygen levels(GO:0036296) |
| 0.2 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
| 0.2 | 1.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.2 | 0.4 | GO:1901166 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.2 | 0.5 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
| 0.2 | 0.3 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.1 | 7.4 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
| 0.1 | 0.1 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.1 | 0.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.1 | 1.5 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
| 0.1 | 14.1 | GO:0006260 | DNA replication(GO:0006260) |
| 0.1 | 0.4 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.1 | 0.8 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.1 | 0.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 0.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.1 | 0.6 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
| 0.1 | 0.6 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 | 0.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 | 0.2 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
| 0.1 | 0.5 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
| 0.0 | 0.4 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.0 | 0.5 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.0 | 0.1 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.0 | 0.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 | 0.0 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.0 | 0.0 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 56.0 | 279.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 47.3 | 378.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 42.5 | 170.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 36.3 | 218.0 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 34.3 | 137.2 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 34.2 | 102.5 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 32.2 | 225.5 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 31.8 | 222.4 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 31.2 | 93.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 31.1 | 373.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 30.3 | 151.3 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 29.5 | 295.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 29.3 | 263.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 29.2 | 146.1 | GO:0033503 | HULC complex(GO:0033503) |
| 27.6 | 82.7 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 26.8 | 268.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 26.8 | 80.3 | GO:1990913 | sperm head plasma membrane(GO:1990913) ooplasm(GO:1990917) |
| 26.4 | 132.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 26.1 | 312.7 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 26.0 | 155.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 25.7 | 154.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 25.6 | 102.4 | GO:0071920 | cleavage body(GO:0071920) |
| 25.1 | 100.4 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 25.1 | 100.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 24.6 | 172.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 24.3 | 681.1 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 24.3 | 97.3 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 24.3 | 72.8 | GO:0044393 | microspike(GO:0044393) |
| 23.4 | 304.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 22.6 | 225.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 22.0 | 88.0 | GO:0071817 | MMXD complex(GO:0071817) |
| 22.0 | 154.0 | GO:0090661 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 21.9 | 350.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 21.7 | 151.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 21.6 | 64.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 21.6 | 43.1 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 21.5 | 64.6 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 21.3 | 212.6 | GO:0097255 | R2TP complex(GO:0097255) |
| 21.2 | 106.1 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 21.1 | 126.9 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 21.0 | 189.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 20.9 | 62.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 20.8 | 124.9 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 20.7 | 82.9 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 20.7 | 62.1 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 20.7 | 62.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 20.4 | 81.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 20.4 | 81.6 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 20.2 | 121.3 | GO:0097422 | tubular endosome(GO:0097422) |
| 20.1 | 784.4 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 19.6 | 78.4 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 19.5 | 97.5 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 19.4 | 77.8 | GO:0071942 | XPC complex(GO:0071942) |
| 19.3 | 77.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 19.3 | 154.3 | GO:0000796 | condensin complex(GO:0000796) |
| 19.2 | 153.9 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 19.1 | 76.2 | GO:0000811 | GINS complex(GO:0000811) |
| 18.6 | 74.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 18.2 | 54.5 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 18.0 | 90.1 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 18.0 | 126.1 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 17.9 | 89.5 | GO:0031523 | Myb complex(GO:0031523) |
| 17.6 | 158.1 | GO:0034709 | methylosome(GO:0034709) |
| 17.5 | 157.4 | GO:0042382 | paraspeckles(GO:0042382) |
| 17.4 | 243.5 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 17.3 | 51.8 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 17.1 | 239.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 17.1 | 222.3 | GO:0005688 | U6 snRNP(GO:0005688) |
| 16.9 | 168.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 16.8 | 117.8 | GO:0016589 | NURF complex(GO:0016589) |
| 16.8 | 67.3 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 16.7 | 116.8 | GO:0030677 | ribonuclease P complex(GO:0030677) |
| 16.5 | 264.3 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 16.5 | 280.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 16.4 | 16.4 | GO:0005687 | U4 snRNP(GO:0005687) |
| 16.4 | 81.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 16.4 | 16.4 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 16.2 | 32.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 16.2 | 259.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 16.1 | 16.1 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 16.0 | 48.0 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 15.8 | 63.4 | GO:1990423 | RZZ complex(GO:1990423) |
| 15.8 | 110.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 15.7 | 15.7 | GO:1990246 | uniplex complex(GO:1990246) |
| 15.7 | 219.2 | GO:0090543 | Flemming body(GO:0090543) |
| 15.6 | 93.9 | GO:1990357 | terminal web(GO:1990357) |
| 15.6 | 31.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 15.5 | 77.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 15.4 | 508.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 15.4 | 199.6 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 15.2 | 121.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 15.0 | 254.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 14.8 | 133.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 14.8 | 413.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 14.7 | 14.7 | GO:0097342 | ripoptosome(GO:0097342) |
| 14.7 | 44.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 14.6 | 58.2 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
| 14.5 | 58.1 | GO:0005715 | late recombination nodule(GO:0005715) |
| 14.5 | 130.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 14.4 | 86.7 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 14.4 | 717.9 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 14.3 | 42.8 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 14.2 | 71.1 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 14.2 | 184.9 | GO:0031209 | SCAR complex(GO:0031209) |
| 14.2 | 56.7 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 14.2 | 70.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 13.9 | 55.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 13.8 | 13.8 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 13.5 | 27.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 13.4 | 26.9 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
| 13.1 | 65.7 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 13.1 | 78.4 | GO:0061617 | MICOS complex(GO:0061617) |
| 13.1 | 91.4 | GO:0031415 | NatA complex(GO:0031415) |
| 13.1 | 39.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 13.1 | 770.1 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 13.0 | 104.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 12.9 | 180.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 12.9 | 64.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 12.8 | 102.6 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 12.7 | 356.7 | GO:0000502 | proteasome complex(GO:0000502) |
| 12.6 | 88.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 12.5 | 112.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 12.4 | 99.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 12.4 | 37.1 | GO:0018444 | translation release factor complex(GO:0018444) |
| 12.4 | 12.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 12.3 | 12.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 12.3 | 73.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 12.3 | 24.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 12.2 | 61.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 12.2 | 24.4 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 12.1 | 12.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 12.0 | 156.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 12.0 | 12.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 12.0 | 24.0 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 11.9 | 83.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 11.9 | 177.9 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 11.8 | 35.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 11.8 | 47.2 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 11.7 | 70.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 11.6 | 69.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 11.5 | 69.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 11.3 | 45.2 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 11.3 | 56.3 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 11.3 | 90.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 11.2 | 123.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 11.1 | 44.4 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 11.1 | 188.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 11.0 | 55.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 11.0 | 33.0 | GO:0032419 | extrinsic component of lysosome membrane(GO:0032419) |
| 10.9 | 131.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 10.9 | 43.5 | GO:0044754 | autolysosome(GO:0044754) |
| 10.9 | 239.2 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 10.9 | 119.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 10.8 | 86.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 10.7 | 320.7 | GO:0031143 | pseudopodium(GO:0031143) |
| 10.6 | 95.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 10.6 | 21.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 10.5 | 31.5 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 10.4 | 114.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 10.4 | 41.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 10.4 | 31.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 10.4 | 238.4 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 10.3 | 113.7 | GO:0097470 | ribbon synapse(GO:0097470) |
| 10.3 | 227.5 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
| 10.3 | 195.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 10.2 | 71.7 | GO:0032021 | NELF complex(GO:0032021) |
| 10.1 | 170.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 10.1 | 80.4 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 10.0 | 119.9 | GO:0042555 | MCM complex(GO:0042555) |
| 10.0 | 159.8 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 10.0 | 29.9 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 9.9 | 238.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 9.7 | 512.7 | GO:0005876 | spindle microtubule(GO:0005876) |
| 9.7 | 174.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 9.7 | 48.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 9.6 | 28.9 | GO:0097441 | basilar dendrite(GO:0097441) |
| 9.6 | 19.2 | GO:0043203 | axon hillock(GO:0043203) |
| 9.6 | 105.7 | GO:0005638 | lamin filament(GO:0005638) |
| 9.6 | 153.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 9.5 | 57.0 | GO:0001940 | male pronucleus(GO:0001940) |
| 9.4 | 28.3 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 9.4 | 132.2 | GO:0032433 | filopodium tip(GO:0032433) |
| 9.4 | 1292.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 9.4 | 47.0 | GO:0070552 | BRISC complex(GO:0070552) |
| 9.4 | 243.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 9.2 | 46.2 | GO:0032449 | CBM complex(GO:0032449) |
| 9.2 | 36.7 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 9.1 | 9.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 9.0 | 578.4 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 9.0 | 45.0 | GO:0043291 | RAVE complex(GO:0043291) |
| 8.9 | 53.2 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
| 8.8 | 52.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 8.8 | 43.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 8.8 | 183.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 8.7 | 200.8 | GO:0030056 | hemidesmosome(GO:0030056) |
| 8.6 | 25.8 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 8.5 | 102.2 | GO:0097449 | astrocyte projection(GO:0097449) |
| 8.4 | 42.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 8.3 | 58.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 8.3 | 99.9 | GO:0071203 | WASH complex(GO:0071203) |
| 8.3 | 99.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 8.2 | 65.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 8.0 | 8.0 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 8.0 | 23.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 7.9 | 31.7 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 7.9 | 23.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 7.8 | 39.2 | GO:0000125 | PCAF complex(GO:0000125) |
| 7.8 | 15.5 | GO:0044094 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 7.7 | 209.2 | GO:0070469 | respiratory chain(GO:0070469) |
| 7.7 | 30.6 | GO:0097452 | GAIT complex(GO:0097452) |
| 7.5 | 90.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 7.5 | 45.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 7.5 | 30.0 | GO:0032059 | bleb(GO:0032059) |
| 7.5 | 82.3 | GO:0005686 | U2 snRNP(GO:0005686) |
| 7.5 | 239.3 | GO:0000776 | kinetochore(GO:0000776) |
| 7.5 | 67.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 7.4 | 22.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 7.3 | 7.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 7.3 | 51.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 7.3 | 29.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 7.3 | 109.2 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 7.3 | 87.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 7.2 | 72.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 7.2 | 35.9 | GO:0071797 | LUBAC complex(GO:0071797) |
| 7.2 | 7.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 7.2 | 42.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 7.0 | 62.6 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 7.0 | 146.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 6.9 | 20.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 6.9 | 75.8 | GO:0070449 | elongin complex(GO:0070449) |
| 6.8 | 20.4 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 6.8 | 13.5 | GO:0035061 | interchromatin granule(GO:0035061) |
| 6.7 | 40.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 6.5 | 25.9 | GO:0005869 | dynactin complex(GO:0005869) |
| 6.4 | 57.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 6.4 | 19.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 6.4 | 31.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 6.4 | 70.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 6.4 | 31.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 6.3 | 165.0 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 6.3 | 539.4 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 6.3 | 50.7 | GO:0051286 | cell tip(GO:0051286) |
| 6.3 | 88.7 | GO:0005685 | U1 snRNP(GO:0005685) |
| 6.3 | 31.6 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 6.3 | 307.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 6.2 | 68.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 6.2 | 242.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 6.1 | 24.5 | GO:0035363 | histone locus body(GO:0035363) |
| 6.1 | 66.7 | GO:0030008 | TRAPP complex(GO:0030008) |
| 6.0 | 126.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 6.0 | 23.9 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 5.9 | 29.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 5.9 | 308.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 5.9 | 604.7 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 5.9 | 11.8 | GO:0030689 | Noc complex(GO:0030689) |
| 5.9 | 242.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 5.9 | 472.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 5.9 | 41.2 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 5.9 | 135.2 | GO:0044295 | axonal growth cone(GO:0044295) |
| 5.9 | 94.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 5.8 | 63.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 5.7 | 73.8 | GO:0016600 | flotillin complex(GO:0016600) |
| 5.7 | 17.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 5.6 | 22.6 | GO:0048179 | activin receptor complex(GO:0048179) |
| 5.6 | 39.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 5.6 | 28.0 | GO:0001739 | sex chromatin(GO:0001739) |
| 5.6 | 89.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 5.6 | 67.1 | GO:0030686 | 90S preribosome(GO:0030686) |
| 5.6 | 27.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 5.5 | 11.1 | GO:0071010 | prespliceosome(GO:0071010) |
| 5.5 | 22.1 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 5.5 | 98.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 5.4 | 783.7 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 5.4 | 16.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 5.3 | 95.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 5.3 | 258.3 | GO:0043034 | costamere(GO:0043034) |
| 5.2 | 52.1 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
| 5.2 | 26.0 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 5.2 | 10.4 | GO:0044308 | axonal spine(GO:0044308) |
| 5.1 | 15.4 | GO:0016938 | kinesin I complex(GO:0016938) |
| 5.1 | 5.1 | GO:0034518 | RNA cap binding complex(GO:0034518) |
| 5.1 | 570.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 5.1 | 174.6 | GO:0071564 | npBAF complex(GO:0071564) |
| 5.1 | 56.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 5.1 | 10.2 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 5.1 | 35.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 5.0 | 151.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 5.0 | 5.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 4.9 | 356.7 | GO:0031970 | organelle envelope lumen(GO:0031970) |
| 4.8 | 24.2 | GO:0032044 | DSIF complex(GO:0032044) |
| 4.8 | 38.7 | GO:0031931 | TORC1 complex(GO:0031931) |
| 4.8 | 43.2 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 4.8 | 90.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 4.8 | 4.8 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 4.8 | 9.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 4.8 | 23.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 4.7 | 71.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 4.6 | 13.7 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
| 4.6 | 41.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 4.5 | 72.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 4.5 | 17.9 | GO:0089701 | U2AF(GO:0089701) |
| 4.4 | 111.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 4.4 | 635.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 4.4 | 1476.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 4.4 | 8.8 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 4.4 | 35.0 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 4.4 | 39.3 | GO:0000124 | SAGA complex(GO:0000124) |
| 4.4 | 8.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 4.3 | 34.3 | GO:0030904 | retromer complex(GO:0030904) |
| 4.3 | 42.8 | GO:0070852 | cell body fiber(GO:0070852) |
| 4.3 | 1953.3 | GO:0005925 | focal adhesion(GO:0005925) |
| 4.2 | 8.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 4.2 | 16.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 4.0 | 24.3 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 4.0 | 19.9 | GO:0072534 | perineuronal net(GO:0072534) |
| 3.9 | 23.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 3.9 | 150.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 3.8 | 15.2 | GO:0070876 | SOSS complex(GO:0070876) |
| 3.8 | 30.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 3.7 | 7.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 3.7 | 14.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 3.7 | 122.2 | GO:0005605 | basal lamina(GO:0005605) |
| 3.7 | 81.4 | GO:0045178 | basal part of cell(GO:0045178) |
| 3.6 | 17.9 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 3.5 | 14.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 3.4 | 37.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 3.3 | 443.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 3.3 | 58.9 | GO:0035861 | site of double-strand break(GO:0035861) |
| 3.2 | 213.3 | GO:0005643 | nuclear pore(GO:0005643) |
| 3.2 | 54.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 3.2 | 25.6 | GO:0070187 | telosome(GO:0070187) |
| 3.1 | 12.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 3.1 | 22.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 3.1 | 186.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
| 3.0 | 27.4 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 3.0 | 18.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 2.9 | 63.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 2.9 | 25.8 | GO:0051233 | spindle midzone(GO:0051233) |
| 2.8 | 59.4 | GO:0031968 | organelle outer membrane(GO:0031968) |
| 2.8 | 50.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 2.8 | 19.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 2.8 | 5.5 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 2.7 | 5.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 2.7 | 62.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 2.7 | 5.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 2.7 | 2.7 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 2.7 | 5.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 2.6 | 39.7 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 2.6 | 62.4 | GO:0031526 | brush border membrane(GO:0031526) |
| 2.6 | 33.4 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 2.5 | 2.5 | GO:1990462 | omegasome(GO:1990462) |
| 2.5 | 20.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 2.5 | 45.2 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 2.5 | 10.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 2.5 | 12.3 | GO:0045180 | basal cortex(GO:0045180) |
| 2.4 | 179.6 | GO:0005840 | ribosome(GO:0005840) |
| 2.4 | 12.0 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 2.4 | 11.9 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 2.3 | 9.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 2.3 | 153.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 2.3 | 6.9 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 2.3 | 29.6 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 2.1 | 8.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 2.1 | 21.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 2.1 | 23.2 | GO:0005955 | calcineurin complex(GO:0005955) |
| 2.1 | 6.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 2.1 | 4.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 2.1 | 20.5 | GO:0031932 | TORC2 complex(GO:0031932) |
| 2.0 | 278.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 2.0 | 4.0 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 2.0 | 21.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 2.0 | 10.0 | GO:0010369 | chromocenter(GO:0010369) |
| 1.9 | 25.2 | GO:0000812 | Swr1 complex(GO:0000812) |
| 1.9 | 4787.9 | GO:0070062 | extracellular exosome(GO:0070062) |
| 1.9 | 1.9 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
| 1.9 | 5.6 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 1.8 | 22.2 | GO:0032040 | small-subunit processome(GO:0032040) |
| 1.8 | 16.4 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 1.8 | 16.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 1.8 | 3.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 1.8 | 5.3 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 1.7 | 19.0 | GO:0090544 | BAF-type complex(GO:0090544) |
| 1.7 | 22.0 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 1.7 | 23.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 1.7 | 8.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 1.6 | 6.5 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 1.6 | 3.1 | GO:0042827 | platelet dense granule(GO:0042827) |
| 1.5 | 10.8 | GO:1990752 | microtubule end(GO:1990752) |
| 1.5 | 1.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 1.4 | 54.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 1.4 | 31.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 1.4 | 1.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 1.3 | 6.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 1.2 | 6.2 | GO:0000346 | transcription export complex(GO:0000346) |
| 1.2 | 53.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 1.2 | 12.2 | GO:0061574 | ASAP complex(GO:0061574) |
| 1.2 | 3.5 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
| 1.1 | 2.3 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 1.1 | 20.4 | GO:0005844 | polysome(GO:0005844) |
| 1.1 | 13.6 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 1.1 | 53.0 | GO:0005811 | lipid particle(GO:0005811) |
| 1.1 | 27.6 | GO:0005795 | Golgi stack(GO:0005795) |
| 1.1 | 168.1 | GO:0005819 | spindle(GO:0005819) |
| 1.0 | 7.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 1.0 | 6.0 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 1.0 | 42.1 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 0.9 | 2.8 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.9 | 1.8 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.8 | 5.7 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.8 | 6.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.8 | 506.8 | GO:0005730 | nucleolus(GO:0005730) |
| 0.7 | 17.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.7 | 2.8 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.7 | 2.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.7 | 4.6 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 0.6 | 14.0 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) |
| 0.6 | 11.1 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.6 | 5.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.6 | 0.6 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 0.6 | 16.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.5 | 3.3 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.4 | 9.4 | GO:0005861 | troponin complex(GO:0005861) |
| 0.4 | 1.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.4 | 4.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.4 | 1.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.4 | 44.4 | GO:1990904 | ribonucleoprotein complex(GO:1990904) |
| 0.4 | 2.1 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.3 | 0.7 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.3 | 3.7 | GO:0030057 | desmosome(GO:0030057) |
| 0.3 | 1.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.3 | 11.0 | GO:0030673 | axolemma(GO:0030673) |
| 0.3 | 4.5 | GO:0045095 | keratin filament(GO:0045095) |
| 0.2 | 0.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.2 | 10.2 | GO:0031966 | mitochondrial membrane(GO:0031966) |
| 0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 0.4 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 0.0 | 0.1 | GO:0005740 | mitochondrial envelope(GO:0005740) |
| 0.0 | 0.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 53.1 | 159.2 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 47.3 | 378.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 45.6 | 182.4 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 43.4 | 130.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 42.6 | 127.7 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 42.5 | 170.0 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 39.9 | 199.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 36.5 | 72.9 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
| 36.1 | 252.8 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 34.1 | 102.4 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 33.5 | 100.6 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 33.4 | 267.4 | GO:0015288 | porin activity(GO:0015288) |
| 33.2 | 199.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 32.4 | 194.3 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 32.3 | 290.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 32.2 | 160.8 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 31.9 | 95.8 | GO:0004638 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 31.8 | 127.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 31.7 | 95.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 31.3 | 125.1 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 31.3 | 93.8 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 31.1 | 93.3 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 31.0 | 123.9 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 30.7 | 92.0 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 30.6 | 91.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 30.3 | 182.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 30.1 | 90.3 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 29.9 | 179.6 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 29.6 | 148.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 29.5 | 88.6 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 29.3 | 175.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 28.1 | 140.4 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 27.9 | 83.8 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 27.8 | 83.4 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 27.5 | 82.5 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 27.2 | 135.8 | GO:1903135 | cupric ion binding(GO:1903135) |
| 27.1 | 108.6 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
| 27.1 | 135.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 26.8 | 80.3 | GO:0002135 | CTP binding(GO:0002135) |
| 26.7 | 106.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 26.6 | 106.4 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 26.5 | 106.0 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 26.4 | 105.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 26.0 | 129.8 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 25.8 | 77.5 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 24.4 | 317.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 24.2 | 96.6 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 24.2 | 193.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 23.6 | 94.6 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 23.3 | 116.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 23.2 | 139.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 23.0 | 68.9 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 22.7 | 113.7 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 22.2 | 88.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 22.1 | 88.3 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 22.0 | 154.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 21.9 | 350.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 21.5 | 150.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 21.5 | 602.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 21.4 | 85.7 | GO:0043515 | kinetochore binding(GO:0043515) |
| 21.3 | 42.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 21.3 | 63.8 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 21.2 | 169.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 21.2 | 169.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 20.9 | 62.7 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 20.9 | 146.2 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 20.8 | 290.6 | GO:0031386 | protein tag(GO:0031386) |
| 20.7 | 62.2 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 20.6 | 20.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 20.4 | 61.3 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
| 20.4 | 142.7 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 20.2 | 141.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 20.1 | 60.2 | GO:0000252 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
| 20.0 | 80.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 20.0 | 120.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 20.0 | 60.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 20.0 | 60.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 20.0 | 79.9 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 19.8 | 119.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 19.8 | 178.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 19.7 | 59.1 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 19.5 | 136.8 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 19.5 | 97.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 19.5 | 58.4 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 19.3 | 154.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 19.2 | 134.3 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 19.2 | 76.7 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 19.0 | 57.0 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 18.8 | 56.5 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 18.8 | 56.5 | GO:0031403 | lithium ion binding(GO:0031403) |
| 18.6 | 167.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 18.5 | 55.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 18.5 | 74.1 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 18.4 | 202.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 18.2 | 72.8 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 18.1 | 108.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 18.1 | 72.3 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 18.1 | 18.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 18.1 | 36.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 18.0 | 90.1 | GO:0032143 | single thymine insertion binding(GO:0032143) |
| 17.9 | 17.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 17.9 | 53.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 17.8 | 53.3 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 17.7 | 70.8 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 17.6 | 52.8 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 17.6 | 175.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 17.6 | 52.7 | GO:0035731 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
| 17.5 | 822.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 17.4 | 52.1 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 17.4 | 52.1 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
| 17.3 | 51.8 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 17.3 | 103.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 17.1 | 17.1 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 17.1 | 34.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 17.1 | 51.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 17.1 | 205.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 16.9 | 474.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 16.8 | 50.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 16.7 | 50.2 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 16.7 | 83.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 16.7 | 167.0 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 16.4 | 65.5 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 16.2 | 65.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 16.1 | 112.8 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 16.1 | 96.6 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 16.0 | 48.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 15.9 | 95.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 15.8 | 110.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 15.6 | 249.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 15.6 | 826.8 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 15.6 | 108.9 | GO:0004470 | malic enzyme activity(GO:0004470) |
| 15.5 | 46.6 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 15.4 | 200.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 15.4 | 92.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 15.3 | 91.7 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 15.3 | 61.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 15.3 | 30.5 | GO:0070404 | NADH binding(GO:0070404) |
| 15.2 | 30.3 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 15.1 | 60.5 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 15.1 | 75.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 15.0 | 60.2 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 15.0 | 15.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 15.0 | 60.0 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 15.0 | 75.0 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 15.0 | 30.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 14.9 | 44.7 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 14.9 | 59.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 14.8 | 89.1 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 14.8 | 59.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 14.7 | 44.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 14.7 | 58.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 14.7 | 175.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 14.6 | 29.2 | GO:0070990 | snRNP binding(GO:0070990) |
| 14.5 | 43.6 | GO:0003896 | DNA primase activity(GO:0003896) |
| 14.5 | 101.3 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 14.2 | 85.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 14.2 | 42.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 14.1 | 84.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 14.1 | 70.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 14.0 | 140.3 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 14.0 | 42.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 14.0 | 251.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 14.0 | 363.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 14.0 | 55.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 13.8 | 55.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 13.7 | 123.4 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 13.6 | 81.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 13.6 | 108.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 13.5 | 81.3 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 13.5 | 135.1 | GO:0042731 | PH domain binding(GO:0042731) |
| 13.4 | 13.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 13.4 | 40.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 13.3 | 40.0 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 13.3 | 479.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 13.3 | 66.3 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 13.1 | 143.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 12.9 | 296.8 | GO:0070628 | proteasome binding(GO:0070628) |
| 12.9 | 64.3 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 12.7 | 76.3 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 12.6 | 50.6 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 12.6 | 88.4 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 12.6 | 37.8 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 12.6 | 88.1 | GO:0005497 | androgen binding(GO:0005497) |
| 12.5 | 62.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 12.5 | 49.9 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 12.5 | 49.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 12.3 | 86.3 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
| 12.3 | 36.9 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 12.3 | 73.7 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 12.3 | 12.3 | GO:0043398 | HLH domain binding(GO:0043398) |
| 12.3 | 134.8 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 12.2 | 97.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 12.2 | 36.5 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 12.1 | 60.4 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 12.1 | 12.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 12.0 | 72.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 11.8 | 23.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 11.8 | 35.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 11.8 | 271.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 11.7 | 82.2 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 11.6 | 46.6 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 11.5 | 299.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 11.3 | 34.0 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 11.2 | 22.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 11.2 | 22.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 11.2 | 78.4 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 11.2 | 33.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 11.1 | 133.7 | GO:0000339 | RNA cap binding(GO:0000339) |
| 11.0 | 11.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
| 10.9 | 349.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 10.9 | 98.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 10.9 | 152.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 10.9 | 32.6 | GO:0048030 | disaccharide binding(GO:0048030) |
| 10.8 | 32.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 10.7 | 32.2 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
| 10.7 | 139.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 10.7 | 117.6 | GO:0038132 | neuregulin binding(GO:0038132) |
| 10.6 | 21.2 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 10.6 | 31.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 10.5 | 31.5 | GO:0055100 | adiponectin binding(GO:0055100) |
| 10.4 | 83.6 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 10.4 | 31.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 10.4 | 187.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 10.4 | 72.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 10.2 | 102.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 10.2 | 102.0 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 10.2 | 81.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 10.1 | 30.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 10.1 | 20.2 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 10.1 | 60.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 10.1 | 171.7 | GO:0043495 | protein anchor(GO:0043495) |
| 10.1 | 40.3 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 10.1 | 80.4 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 10.0 | 110.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 10.0 | 29.9 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 10.0 | 39.8 | GO:0015266 | protein channel activity(GO:0015266) |
| 10.0 | 278.7 | GO:0017166 | vinculin binding(GO:0017166) |
| 10.0 | 49.8 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 9.9 | 79.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 9.8 | 49.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 9.7 | 107.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 9.7 | 77.4 | GO:0030911 | TPR domain binding(GO:0030911) |
| 9.5 | 713.6 | GO:0019003 | GDP binding(GO:0019003) |
| 9.5 | 37.9 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 9.4 | 103.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 9.4 | 28.2 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 9.4 | 253.3 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 9.3 | 112.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 9.3 | 9.3 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 9.3 | 74.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 9.3 | 27.9 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 9.2 | 46.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 9.2 | 27.5 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 9.2 | 27.5 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 9.2 | 82.4 | GO:0089720 | caspase binding(GO:0089720) |
| 9.1 | 27.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 9.1 | 255.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 9.1 | 27.3 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 9.1 | 9.1 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) |
| 9.1 | 45.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 9.1 | 190.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 9.1 | 99.6 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 9.0 | 72.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 9.0 | 205.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 8.9 | 517.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 8.9 | 62.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 8.9 | 17.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 8.8 | 114.6 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 8.8 | 52.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 8.7 | 156.5 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 8.7 | 1799.8 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 8.6 | 8.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 8.6 | 43.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
| 8.6 | 17.1 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
| 8.5 | 25.5 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 8.4 | 33.8 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 8.4 | 16.9 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 8.4 | 50.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 8.4 | 8.4 | GO:0047718 | geranylgeranyl reductase activity(GO:0045550) indanol dehydrogenase activity(GO:0047718) |
| 8.3 | 25.0 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 8.3 | 75.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 8.3 | 25.0 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 8.3 | 66.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 8.3 | 24.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 8.3 | 156.8 | GO:0051400 | BH domain binding(GO:0051400) |
| 8.2 | 82.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 8.2 | 24.5 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
| 8.2 | 155.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 8.2 | 155.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 8.2 | 40.8 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 8.2 | 228.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 8.1 | 8.1 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
| 8.1 | 24.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 8.1 | 382.2 | GO:0050699 | WW domain binding(GO:0050699) |
| 8.1 | 24.4 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 8.1 | 64.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 8.1 | 40.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 8.1 | 16.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 8.1 | 24.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 8.0 | 88.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 8.0 | 80.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 8.0 | 8.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 7.9 | 15.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 7.9 | 71.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 7.9 | 213.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 7.9 | 3031.9 | GO:0045296 | cadherin binding(GO:0045296) |
| 7.9 | 23.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 7.8 | 47.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 7.8 | 39.1 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 7.8 | 15.6 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
| 7.8 | 93.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 7.7 | 61.9 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 7.7 | 183.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 7.6 | 45.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 7.6 | 15.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 7.5 | 7.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 7.4 | 22.3 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 7.4 | 96.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 7.4 | 29.5 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 7.4 | 103.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 7.3 | 36.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 7.2 | 14.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 7.2 | 7.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 7.1 | 35.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 7.1 | 21.4 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 7.0 | 14.0 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 6.9 | 131.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 6.9 | 104.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 6.9 | 193.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 6.9 | 103.2 | GO:0008483 | transaminase activity(GO:0008483) |
| 6.8 | 13.7 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 6.8 | 6.8 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 6.8 | 197.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 6.7 | 20.1 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
| 6.7 | 20.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 6.6 | 59.8 | GO:0034452 | dynactin binding(GO:0034452) |
| 6.6 | 26.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 6.6 | 52.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 6.6 | 19.7 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 6.6 | 19.7 | GO:0016936 | galactoside binding(GO:0016936) |
| 6.5 | 26.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 6.5 | 13.0 | GO:1990254 | keratin filament binding(GO:1990254) |
| 6.5 | 19.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 6.5 | 45.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 6.5 | 25.9 | GO:0071253 | connexin binding(GO:0071253) |
| 6.5 | 19.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 6.4 | 6.4 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
| 6.4 | 57.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 6.4 | 25.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 6.4 | 44.8 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 6.4 | 38.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 6.3 | 31.4 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 6.3 | 31.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 6.2 | 37.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 6.2 | 49.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 6.2 | 12.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 6.2 | 24.8 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 6.2 | 98.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 6.2 | 43.3 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
| 6.2 | 18.5 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 6.1 | 85.6 | GO:0050544 | icosanoid binding(GO:0050542) icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
| 6.1 | 18.3 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 6.0 | 6.0 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 6.0 | 47.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 5.9 | 53.3 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 5.9 | 17.7 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 5.9 | 177.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 5.9 | 17.7 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 5.8 | 23.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 5.8 | 52.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 5.8 | 34.8 | GO:0004064 | arylesterase activity(GO:0004064) |
| 5.8 | 28.9 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 5.7 | 51.7 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 5.7 | 17.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 5.7 | 68.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 5.7 | 22.8 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 5.7 | 34.0 | GO:0036033 | mediator complex binding(GO:0036033) |
| 5.7 | 28.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 5.6 | 39.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 5.6 | 50.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 5.5 | 5.5 | GO:0004335 | galactokinase activity(GO:0004335) |
| 5.5 | 22.2 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 5.5 | 55.0 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 5.5 | 153.9 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 5.4 | 206.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 5.4 | 113.8 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 5.4 | 10.8 | GO:0034046 | poly(G) binding(GO:0034046) |
| 5.4 | 183.4 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 5.4 | 21.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 5.4 | 161.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 5.4 | 75.1 | GO:0031489 | myosin V binding(GO:0031489) |
| 5.4 | 782.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 5.4 | 21.4 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 5.3 | 16.0 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 5.3 | 68.8 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 5.3 | 21.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 5.3 | 5.3 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 5.3 | 26.3 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 5.3 | 15.8 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 5.2 | 21.0 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 5.2 | 15.7 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 5.2 | 67.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 5.2 | 5.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 5.2 | 15.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 5.2 | 67.2 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 5.2 | 25.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 5.1 | 46.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 5.1 | 15.4 | GO:0036505 | prosaposin receptor activity(GO:0036505) |
| 5.1 | 107.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 5.1 | 35.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 5.1 | 136.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 5.1 | 5.1 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
| 5.0 | 30.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 5.0 | 20.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 5.0 | 15.0 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 5.0 | 85.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 4.9 | 14.6 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 4.9 | 151.3 | GO:0043236 | laminin binding(GO:0043236) |
| 4.9 | 19.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 4.8 | 19.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 4.8 | 24.0 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 4.8 | 162.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 4.8 | 14.4 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 4.8 | 42.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 4.8 | 162.0 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 4.8 | 147.6 | GO:0005123 | death receptor binding(GO:0005123) |
| 4.7 | 90.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 4.7 | 212.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 4.7 | 42.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 4.7 | 56.4 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 4.7 | 84.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 4.7 | 46.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 4.6 | 78.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 4.6 | 64.6 | GO:0031014 | troponin T binding(GO:0031014) |
| 4.6 | 4.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 4.6 | 4.6 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 4.6 | 4.6 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 4.6 | 82.1 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 4.6 | 4.6 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 4.5 | 72.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 4.5 | 18.0 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
| 4.5 | 166.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 4.5 | 13.4 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 4.4 | 61.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 4.4 | 30.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 4.4 | 30.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 4.4 | 157.7 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 4.4 | 17.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 4.4 | 17.5 | GO:0070513 | death domain binding(GO:0070513) |
| 4.3 | 64.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 4.3 | 34.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 4.3 | 8.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 4.3 | 68.4 | GO:0044548 | S100 protein binding(GO:0044548) |
| 4.3 | 51.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 4.3 | 42.6 | GO:0043295 | glutathione binding(GO:0043295) |
| 4.2 | 41.8 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 4.2 | 41.8 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 4.2 | 4.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 4.2 | 16.7 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
| 4.2 | 37.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 4.2 | 33.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 4.1 | 24.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 4.1 | 20.6 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 4.1 | 78.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 4.1 | 20.5 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 4.1 | 12.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 4.1 | 53.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 4.1 | 12.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 4.1 | 56.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 4.0 | 68.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 4.0 | 36.2 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 4.0 | 12.1 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 4.0 | 56.1 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 4.0 | 7.9 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 4.0 | 538.5 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 4.0 | 19.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 3.9 | 149.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 3.9 | 27.5 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 3.9 | 15.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 3.9 | 7.8 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 3.9 | 3.9 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 3.9 | 23.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 3.9 | 19.4 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 3.9 | 11.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 3.9 | 46.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 3.8 | 23.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 3.8 | 3.8 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 3.8 | 7.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 3.8 | 18.9 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 3.8 | 11.3 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 3.8 | 18.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 3.7 | 321.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 3.7 | 33.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 3.7 | 70.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 3.7 | 149.1 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 3.7 | 18.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 3.7 | 18.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 3.7 | 69.5 | GO:0034062 | RNA polymerase activity(GO:0034062) |
| 3.6 | 7.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 3.6 | 14.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 3.6 | 43.1 | GO:0046790 | virion binding(GO:0046790) |
| 3.5 | 24.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 3.5 | 118.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 3.5 | 216.5 | GO:0008565 | protein transporter activity(GO:0008565) |
| 3.5 | 3.5 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 3.5 | 41.7 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 3.5 | 76.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 3.5 | 138.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 3.5 | 48.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 3.4 | 20.7 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 3.4 | 16.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 3.4 | 16.9 | GO:0097016 | L27 domain binding(GO:0097016) |
| 3.4 | 6.7 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 3.4 | 6.7 | GO:0000182 | rDNA binding(GO:0000182) |
| 3.3 | 6.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 3.3 | 16.7 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 3.3 | 10.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 3.3 | 26.7 | GO:0050733 | RS domain binding(GO:0050733) |
| 3.3 | 6.6 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 3.3 | 78.4 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 3.3 | 16.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 3.2 | 68.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 3.2 | 9.7 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 3.2 | 84.1 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 3.2 | 15.9 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
| 3.1 | 9.4 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 3.1 | 173.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 3.1 | 75.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 3.1 | 9.3 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 3.1 | 37.1 | GO:0030515 | snoRNA binding(GO:0030515) |
| 3.1 | 3.1 | GO:0016419 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
| 3.0 | 15.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 3.0 | 9.1 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 3.0 | 3.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 3.0 | 60.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 3.0 | 12.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
| 3.0 | 3.0 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 3.0 | 14.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 3.0 | 175.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 3.0 | 23.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 2.9 | 47.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 2.9 | 64.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 2.9 | 11.7 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 2.9 | 11.6 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 2.9 | 17.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 2.9 | 17.4 | GO:0045545 | syndecan binding(GO:0045545) |
| 2.8 | 14.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 2.8 | 17.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
| 2.8 | 5.7 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 2.8 | 22.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 2.8 | 86.2 | GO:0003785 | actin monomer binding(GO:0003785) |
| 2.8 | 19.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 2.7 | 16.4 | GO:0031491 | nucleosome binding(GO:0031491) |
| 2.7 | 16.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 2.7 | 27.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 2.7 | 56.9 | GO:0000049 | tRNA binding(GO:0000049) |
| 2.7 | 32.0 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 2.7 | 32.0 | GO:0031404 | chloride ion binding(GO:0031404) |
| 2.7 | 58.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 2.6 | 18.5 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 2.6 | 71.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 2.6 | 7.9 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 2.6 | 257.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 2.6 | 15.6 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
| 2.6 | 18.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 2.6 | 43.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 2.6 | 87.8 | GO:0009055 | electron carrier activity(GO:0009055) |
| 2.6 | 5.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 2.5 | 15.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 2.5 | 58.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 2.5 | 70.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 2.5 | 9.9 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 2.5 | 12.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 2.4 | 44.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 2.4 | 12.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 2.4 | 9.6 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 2.4 | 12.0 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 2.4 | 2.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 2.3 | 7.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 2.3 | 7.0 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 2.3 | 34.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 2.3 | 4.7 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 2.3 | 36.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 2.2 | 4.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 2.2 | 20.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 2.2 | 8.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 2.2 | 6.6 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 2.2 | 19.7 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 2.2 | 56.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 2.2 | 13.0 | GO:0016015 | morphogen activity(GO:0016015) |
| 2.1 | 6.4 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 2.1 | 6.3 | GO:0031208 | POZ domain binding(GO:0031208) |
| 2.1 | 20.9 | GO:0055103 | ligase regulator activity(GO:0055103) |
| 2.1 | 16.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 2.1 | 12.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 2.1 | 95.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 2.1 | 2210.9 | GO:0003723 | RNA binding(GO:0003723) |
| 2.0 | 10.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 2.0 | 2.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 2.0 | 14.2 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 2.0 | 316.6 | GO:0003924 | GTPase activity(GO:0003924) |
| 2.0 | 13.7 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 1.9 | 5.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 1.9 | 5.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 1.9 | 9.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 1.9 | 24.5 | GO:0008527 | taste receptor activity(GO:0008527) |
| 1.9 | 220.7 | GO:0005178 | integrin binding(GO:0005178) |
| 1.9 | 7.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 1.9 | 22.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 1.8 | 12.6 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 1.8 | 7.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.8 | 1.8 | GO:0045118 | azole transporter activity(GO:0045118) |
| 1.8 | 10.6 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 1.8 | 21.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 1.8 | 7.0 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
| 1.7 | 19.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 1.7 | 28.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 1.7 | 13.7 | GO:0051425 | PTB domain binding(GO:0051425) |
| 1.7 | 6.8 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 1.7 | 3.4 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 1.7 | 5.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 1.6 | 14.7 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 1.6 | 4.8 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 1.6 | 128.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 1.6 | 4.7 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 1.6 | 14.1 | GO:0039706 | co-receptor binding(GO:0039706) |
| 1.6 | 1.6 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 1.5 | 15.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 1.5 | 6.2 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 1.5 | 7.7 | GO:0050700 | CARD domain binding(GO:0050700) |
| 1.5 | 4.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 1.4 | 5.8 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 1.4 | 5.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 1.4 | 4.2 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 1.4 | 5.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 1.4 | 6.8 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 1.4 | 2.7 | GO:0070697 | activin receptor binding(GO:0070697) |
| 1.3 | 9.4 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 1.3 | 31.6 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 1.3 | 41.8 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 1.3 | 3.9 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 1.3 | 10.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 1.3 | 3.9 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 1.3 | 6.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 1.3 | 5.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 1.2 | 18.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 1.2 | 15.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 1.2 | 8.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 1.2 | 28.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 1.2 | 4.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 1.2 | 5.8 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
| 1.1 | 50.1 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
| 1.1 | 8.9 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 1.1 | 10.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 1.1 | 15.0 | GO:0043531 | ADP binding(GO:0043531) |
| 1.1 | 113.1 | GO:0042393 | histone binding(GO:0042393) |
| 1.1 | 10.7 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 1.0 | 21.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 1.0 | 1.0 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
| 1.0 | 4.8 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.9 | 6.4 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.9 | 3.6 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
| 0.9 | 13.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.8 | 5.7 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.8 | 3.3 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.8 | 2.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.8 | 25.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.8 | 14.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.7 | 20.8 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.7 | 24.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.7 | 2.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.6 | 0.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.6 | 3.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.6 | 3.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.6 | 3.1 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.6 | 30.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.6 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
| 0.6 | 20.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.6 | 2.9 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.6 | 2.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.5 | 3.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.5 | 0.5 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
| 0.5 | 2.0 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.5 | 0.5 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 0.5 | 1.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.5 | 6.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.4 | 0.4 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 0.4 | 0.9 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.4 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.4 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.4 | 0.8 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.4 | 3.6 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.4 | 6.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.3 | 11.7 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.3 | 1.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.3 | 1.4 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.3 | 0.9 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
| 0.3 | 1.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.3 | 6.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.2 | 0.7 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.2 | 0.7 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
| 0.2 | 0.5 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.2 | 0.7 | GO:0002046 | opsin binding(GO:0002046) |
| 0.2 | 0.6 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.2 | 2.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.2 | 0.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.2 | 0.7 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.1 | 1.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 2.1 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 2.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.1 | 1.2 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.1 | 0.4 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.1 | 0.1 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
| 0.1 | 0.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 1.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 0.5 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.0 | 2.0 | GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0016616) |
| 0.0 | 1.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 1.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.0 | 0.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 30.0 | 60.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 14.1 | 183.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 13.9 | 1917.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 13.8 | 841.4 | PID AURORA B PATHWAY | Aurora B signaling |
| 12.7 | 595.5 | PID PLK1 PATHWAY | PLK1 signaling events |
| 12.1 | 665.3 | PID ATR PATHWAY | ATR signaling pathway |
| 12.1 | 494.5 | PID BARD1 PATHWAY | BARD1 signaling events |
| 11.6 | 255.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 10.4 | 260.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 9.8 | 462.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 9.8 | 205.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 9.4 | 383.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 9.3 | 176.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 8.3 | 149.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 8.2 | 98.2 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 8.1 | 486.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 7.3 | 73.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 7.2 | 193.4 | PID ATM PATHWAY | ATM pathway |
| 6.9 | 569.8 | PID E2F PATHWAY | E2F transcription factor network |
| 6.7 | 469.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 6.7 | 280.1 | PID ALK1 PATHWAY | ALK1 signaling events |
| 6.3 | 62.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 6.3 | 181.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 5.6 | 113.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 5.5 | 136.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 5.3 | 180.8 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 5.3 | 191.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 5.3 | 284.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 5.2 | 167.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 5.2 | 20.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 5.0 | 35.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 4.9 | 108.8 | PID IGF1 PATHWAY | IGF1 pathway |
| 4.9 | 345.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 4.8 | 140.0 | PID RHOA PATHWAY | RhoA signaling pathway |
| 4.6 | 247.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 4.5 | 159.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 4.5 | 138.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 4.4 | 250.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 4.4 | 30.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 4.3 | 281.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 4.3 | 213.7 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 4.2 | 67.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 4.1 | 252.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 3.8 | 72.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 3.7 | 103.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 3.6 | 78.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 3.5 | 56.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 3.5 | 313.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 3.4 | 27.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 3.3 | 153.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 3.3 | 43.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 3.1 | 122.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 3.1 | 34.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 3.1 | 37.5 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 3.1 | 31.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 3.1 | 52.9 | PID AURORA A PATHWAY | Aurora A signaling |
| 3.1 | 9.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 3.0 | 93.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 2.9 | 135.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 2.8 | 323.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 2.8 | 33.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 2.8 | 130.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 2.7 | 21.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 2.7 | 101.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 2.6 | 133.7 | PID P73PATHWAY | p73 transcription factor network |
| 2.6 | 148.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 2.4 | 105.3 | PID CDC42 PATHWAY | CDC42 signaling events |
| 2.4 | 49.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 2.1 | 44.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 2.1 | 6.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 2.0 | 36.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 1.9 | 7.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 1.9 | 95.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 1.8 | 41.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 1.7 | 44.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 1.6 | 57.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 1.6 | 58.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 1.6 | 10.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 1.1 | 5.6 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 1.1 | 27.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 1.1 | 30.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 1.0 | 6.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.9 | 13.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.9 | 15.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.9 | 19.8 | PID FOXO PATHWAY | FoxO family signaling |
| 0.9 | 16.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.8 | 25.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.8 | 6.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.7 | 3.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.7 | 6.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.7 | 14.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.7 | 15.7 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.6 | 5.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.6 | 12.6 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.6 | 16.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.6 | 7.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.5 | 2.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.5 | 40.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.4 | 7.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.4 | 7.7 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.4 | 7.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.4 | 15.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.4 | 10.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.3 | 2.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.3 | 0.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 34.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 0.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.1 | 1.5 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 0.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 29.4 | 29.4 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 27.5 | 192.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 26.7 | 880.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 26.3 | 840.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 22.0 | 1606.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 21.6 | 345.8 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 21.2 | 487.9 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 20.5 | 308.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 20.2 | 747.5 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 20.0 | 300.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 19.2 | 440.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 19.1 | 286.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 18.9 | 75.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 18.2 | 200.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 17.8 | 178.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 17.7 | 158.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 17.4 | 139.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 16.6 | 448.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 16.6 | 944.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 16.4 | 16.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 16.4 | 558.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 16.0 | 448.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 15.6 | 437.6 | REACTOME KINESINS | Genes involved in Kinesins |
| 15.4 | 92.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 15.2 | 1215.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 15.0 | 599.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 14.2 | 169.9 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 13.9 | 27.8 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 13.9 | 166.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 13.8 | 124.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 13.6 | 218.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 13.6 | 95.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 13.4 | 201.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 13.1 | 446.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 13.1 | 222.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 13.0 | 26.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 13.0 | 687.4 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 12.8 | 205.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 12.7 | 267.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 12.6 | 442.7 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 12.5 | 461.0 | REACTOME S PHASE | Genes involved in S Phase |
| 12.4 | 472.1 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 12.2 | 134.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 12.1 | 400.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 12.1 | 72.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 12.0 | 299.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 11.9 | 369.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 11.9 | 130.6 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 11.9 | 142.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 11.8 | 270.5 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 11.4 | 480.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 11.4 | 216.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 11.0 | 573.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 10.9 | 272.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 10.5 | 315.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 10.4 | 697.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 10.2 | 245.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 10.2 | 51.2 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 10.2 | 20.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 9.5 | 142.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 9.4 | 159.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 9.3 | 18.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 9.1 | 127.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 9.0 | 36.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 8.7 | 35.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 8.7 | 260.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 8.5 | 307.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 8.5 | 153.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 8.5 | 203.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 8.4 | 243.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 8.2 | 206.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 7.9 | 495.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 7.5 | 143.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 7.5 | 82.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 7.4 | 126.0 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 7.3 | 58.7 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 7.2 | 78.9 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 7.1 | 114.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 7.1 | 512.7 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 7.1 | 839.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 6.9 | 610.4 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 6.8 | 176.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 6.7 | 60.5 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 6.7 | 275.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 6.7 | 33.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 6.7 | 153.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 6.4 | 216.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 6.3 | 151.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 6.1 | 79.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 5.9 | 58.8 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 5.6 | 73.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 5.3 | 10.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 5.3 | 754.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 5.3 | 73.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 5.1 | 20.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 5.0 | 163.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 4.9 | 118.2 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
| 4.8 | 43.1 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
| 4.8 | 119.3 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 4.8 | 486.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
| 4.8 | 228.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 4.7 | 46.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 4.7 | 270.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 4.5 | 112.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 4.5 | 125.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 4.4 | 119.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 4.1 | 124.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 4.1 | 169.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 4.1 | 247.5 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
| 4.0 | 201.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 4.0 | 52.2 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 4.0 | 52.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 3.9 | 78.8 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 3.9 | 92.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 3.8 | 30.8 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 3.8 | 90.7 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 3.7 | 62.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 3.6 | 14.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 3.5 | 10.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
| 3.4 | 320.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 3.4 | 91.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 3.3 | 80.3 | REACTOME TRANSLATION | Genes involved in Translation |
| 3.2 | 25.6 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
| 3.2 | 31.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 3.1 | 68.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 3.1 | 37.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 2.9 | 99.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 2.9 | 28.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 2.8 | 22.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 2.8 | 82.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 2.7 | 35.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 2.7 | 223.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 2.6 | 63.5 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 2.6 | 39.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 2.6 | 26.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 2.6 | 264.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 2.5 | 66.9 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 2.5 | 49.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 2.4 | 62.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 2.4 | 28.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 2.4 | 54.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 2.3 | 16.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 2.3 | 46.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 2.1 | 6.3 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
| 2.0 | 26.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 2.0 | 5.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 1.9 | 208.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 1.9 | 31.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 1.8 | 28.7 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 1.8 | 50.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 1.8 | 8.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 1.7 | 105.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 1.7 | 22.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 1.7 | 147.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 1.7 | 18.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 1.6 | 26.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 1.6 | 25.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 1.6 | 95.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 1.6 | 25.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 1.4 | 20.9 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 1.3 | 15.5 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 1.3 | 1.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 1.3 | 14.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 1.2 | 22.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 1.2 | 7.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
| 1.2 | 15.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 1.1 | 22.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 1.1 | 24.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 1.0 | 9.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.9 | 16.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.9 | 4.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.9 | 8.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.9 | 1.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.9 | 12.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.8 | 2.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.8 | 16.1 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.8 | 11.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
| 0.8 | 80.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.8 | 73.9 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.6 | 12.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.6 | 3.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.6 | 9.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.5 | 10.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.5 | 6.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.4 | 8.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.3 | 4.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.3 | 3.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.3 | 0.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.3 | 1.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.2 | 5.3 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.1 | 4.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.0 | 1.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 2.4 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |